These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10487460)
1. Lymphocyte response to superantigen in a patient with childhood-onset pityriasis rubra pilaris. Yamamoto T; Yokoyama A Int J Dermatol; 1999 Aug; 38(8):639-40. PubMed ID: 10487460 [No Abstract] [Full Text] [Related]
2. Pityriasis rubra pilaris as a systemic disease. Kamarachev J; Grozdev I; Darlenski R; Tsankov N Clin Dermatol; 2019; 37(6):657-662. PubMed ID: 31864444 [TBL] [Abstract][Full Text] [Related]
3. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. Karimian-Teherani D; Parissa M; Tanew A Pediatr Dermatol; 2008; 25(1):125-6. PubMed ID: 18304175 [TBL] [Abstract][Full Text] [Related]
4. Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two new cases. Möhrenschlager M; Abeck D Pediatr Dermatol; 2002; 19(6):569. PubMed ID: 12437571 [No Abstract] [Full Text] [Related]
5. [Pityriasis rubra pilaris in a patient with acquired immunodeficiency syndrome]. Le Bozec P; Janier M; Reygagne P; Pinquier L; Blanchet-Bardon C; Dubertret L Ann Dermatol Venereol; 1991; 118(11):862-4. PubMed ID: 1789662 [No Abstract] [Full Text] [Related]
6. Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis. Polat M; Lenk N; Ustün H; Oztaş P; Artüz F; Alli N Pediatr Dermatol; 2007; 24(2):151-4. PubMed ID: 17461814 [TBL] [Abstract][Full Text] [Related]